Figure 1From: Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young childrenSimilar efficacy across body weight groups with crushed AL tablet and dispersible AL tablet (PCR-corrected cure rate in the modified intent-to-treat population). Adapted from Abdulla et al [12].Back to article page